-+ 0.00%
-+ 0.00%
-+ 0.00%

Moderna plans private placement of $2 billion convertible senior notes due 2032

PUBT·08/27/2026 12:50:52
Listen to the news
Moderna plans private placement of $2 billion convertible senior notes due 2032
  • Moderna launched a private placement of USD 2 billion Convertible Senior Notes due 2032, sold only to qualified institutional buyers under Rule 144A.
  • Initial purchasers received an option to buy up to an additional USD 300 million of the notes within 13 days of issuance.
  • Convertible Senior Notes due 2032 will be senior unsecured obligations with no regular interest; principal will not accrete.
  • Conversions may be settled in cash, shares, or a mix, at Moderna’s election; final terms set at pricing.
  • Net proceeds earmarked for capped call transactions, general corporate purposes, oncology investment flexibility, debt repayment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moderna Inc. published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.